GLP-1 / incretin

Tirzepatide

Also known as Mounjaro, Zepbound.

What it is

A dual agonist hitting both the GIP and GLP-1 receptors, which tends to produce a larger appetite and metabolic effect than single-pathway GLP-1 drugs.

Used for

Used for appetite regulation and weight management, titrated upward over weeks.

Half-life

~5 days (once-weekly dosing)

Handling

Refrigerate reconstituted vials; protect from light, swirl gently rather than shake.

Watch for

Same GI profile as GLP-1s, sometimes more pronounced; slow titration matters.

Calculate a dose →See its levels over time →

Educational reference only — not medical advice, not a recommendation to use Tirzepatide.